Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
36.22
-0.63 (-1.71%)
Aug 20, 2026, 10:07 AM EDT - Market open
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $6.29 billion as of August 20, 2026. Its market cap has increased by 282.46% in one year.
Market Cap
6.29B
Enterprise Value
5.74B
1-Year Change
282.46%
Ranking
Category
Stock Price
$36.22
ChartMarket Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $6.29B, an increase of 4,958.84%. That is a compound annual growth rate of 89.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 6.29B | 16.34% |
| Dec 31, 2025 | 5.40B | 527.16% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Scholar Rock Holding | 6.88B |
| Belite Bio | 6.79B |
| Mirum Pharmaceuticals | 6.64B |
| Caris Life Sciences | 6.43B |
| Dianthus Therapeutics | 6.36B |
| Erasca | 6.32B |
| Travere Therapeutics | 6.22B |
| Definium Therapeutics | 6.16B |